-
[drug news] China's first second-generation lung cancer targeting drug approved competition leads to price reduction of drug companies
Time of Update: 2017-03-23
Lung cancer is one of the most common malignant tumors in China Incidence rate of lung cancer accounted for 1 million 800 thousand cases in 2012, accounting for 13% of all cancer incidence rate By 201
-
[niurenbang] top 10 Chinese innovative drug R & D leaders: who is your elder brother?
Time of Update: 2017-03-22
"Scientist" and "entrepreneur" are two labels with different attributes In the traditional thinking, there is a magic spell for a scientist to start a business As for EQ, limited by the environment, t
-
Lilly Global CEO: plans to launch 30 new products in China and hopes to cooperate with Chinese innovative pharmaceutical companies
Time of Update: 2017-03-22
In 2016, Lilly announced the distribution and promotion of its antibiotic products in the Chinese mainland market to Yiteng, which is also the fifth case last year for multinational pharmaceutical companies to carry out commercial cooperation between product lines and local enterprises The cooperation agreement officially started on January 1, 2017 The question is, will Lilly have the next product to sell China's rights and interests for strategic reasons?
-
Circular of the General Administration of the people's Republic of China on the issuance of the catalogue of generic reference preparations (the second batch)
Time of Update: 2017-03-20
According to the review and determination of the Expert Committee on the conformity evaluation of quality and efficacy of generic drugs by the State Food and drug administration, the catalogue of gene
-
Circular of the General Administration of the people's Republic of China on Soliciting Opinions on the decision of adjusting the registration and administration of imported drugs
Time of Update: 2017-03-20
In accordance with the requirements of the opinions of the State Council on the reform of the review and approval system for pharmaceutical and medical devices (GF [2015] No 44), in order to encourag
-
China Resources pharmaceutical's revenue is 139.3 billion yuan! Who will be merged in 2017?
Time of Update: 2017-03-20
On March 17, China Resources pharmaceutical released its first report card since its listing, achieving a revenue of 139.3 billion yuan and a net profit of 5.3 billion yuan, with an overall growth com
-
2016 drug review report
Time of Update: 2017-03-20
In 2016, the State Food and Drug Administration continued to adhere to the principles of quality, fairness and efficiency, adhere to the laws and regulations, scientific and normative review, approve
-
Domestic exclusive varieties enter the harvest period: a closer look at the market growth of 5 representative products of Beida, Hengrui, etc
Time of Update: 2017-03-14
The recently released 2017 version of the national medical insurance catalogue has 339 new varieties compared with the 2009 version of the catalogue, including 62 exclusive varieties of Western medici
-
Ding Liming: research and development of orphan drugs should arouse the enthusiasm of domestic enterprises
Time of Update: 2017-03-14
Highlights at the two sessions in 2017, Ding liming, deputy to the National People's Congress and chairman of Zhejiang Beida Pharmaceutical Co., Ltd., said in an interview with minenet that the CPC Ce
-
Practice open cooperation and promote pharmaceutical innovation: Sanofi and Suzhou Institute of systems medicine jointly held a seminar on innovative drugs
Time of Update: 2017-03-13
In order to promote exchanges in this field, Sanofi Asia Pacific R & D headquarters and the center for systems medicine of the Chinese Academy of Medical Sciences and Suzhou Institute of systems medi
-
Geli's new hepatitis C drug has won the priority review and is "close to the market"
Time of Update: 2017-03-03
On February 28, according to the information publicized by the drug review center of the State Food and drug administration, the listing application of danorevir sodium, a new hepatitis C drug of Geli
-
Progress of major new drug development projects in China in 2016
Time of Update: 2017-03-03
1 In October 2016, conbercept eye injection, a national class I new biological drug developed by Kanghong in Chengdu, was approved by FDA It can directly carry out phase III clinical trials in the Uni
-
The first irreversibly targeted lung cancer drug approved in China
Time of Update: 2017-03-01
Shanghai - March 1, 2017, German pharmaceutical giant bringer Ingelheim announced that the company's first non-small cell lung cancer treatment product, giotrif, the world's first and only listed irre
-
China's new drug safety assessment is in line with the international standards, and 30 original new drugs will be tackled in the 13th five year plan
Time of Update: 2017-02-28
It was learned at the press conference of national science and technology major project of major new drug creation (hereinafter referred to as "new drug project") that China's preclinical safety asse
-
[heavyweight] China's new drug has emerged
Time of Update: 2017-02-27
Two photon microscope displayed by Suzhou Institute of biomedical engineering technology, Chinese Academy of Sciences The researchers of Wuhan Youzhi biopharmaceutical Co., Ltd are conducting experime
-
China's pharmaceutical research is changing from "China new" to "global new"
Time of Update: 2017-02-21
Since the implementation of the new registration and classification reform of chemicals, 539 applications for registration of chemicals have been filed according to the new registration and classifica
-
Domestic first imitation: "heavy bomb class" anti lung cancer first-line drug gefitinib (IRICO) on the market!!
Time of Update: 2017-02-19
On February 18, the first successful imitation of Qilu pharmaceutical and the first-line target specific drug "heavy bomb" for the treatment of non-small cell lung cancer (IRICO) listing meeting and t
-
Insight: CDE drug review report in January 2017
Time of Update: 2017-02-12
In December, the number of hot spots declared in January 2017 was basically the same as that in the second half of 2016, and the acceptance of CDE review tended to be stable In the first month of 2017
-
[list] top 100 enterprises applying for generic drugs in 2016
Time of Update: 2017-02-09
2016 is the year with the strictest policy regulation in the pharmaceutical industry, and it is also a year when many pharmaceutical enterprises are dying The whole industry has not fully awakened fro
-
"Peg drug" of innovative drug structure design
Time of Update: 2017-02-06
notes preceding the text of a book or following the title of an article At first, I knew that polyethylene glycol (PEG) was a substance originated from the undergraduate course "pharmaceutical prepara
